Advanced Enzyme
Ticker > Company >

Advanced Enzyme share price

Advanced Enzyme Technologies Ltd.

NSE: ADVENZYMES BSE: 540025 SECTOR: Pharmaceuticals & Drugs  1.02 L   448   76

331.20
-0.70 (-0.21%)
BSE: Today, 01:36 PM

Price Summary

Today's High

₹ 335.8

Today's Low

₹ 330.05

52 Week High

₹ 571.15

52 Week Low

₹ 257.85

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 3705.5 Cr.

Enterprise Value

₹ 3699.67 Cr.

No. of Shares

11.19 Cr.

P/E

36.18

P/B

5.93

Face Value

₹ 2

Div. Yield

1.56 %

Book Value (TTM)

₹  55.81

CASH

₹ 5.83 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

43.08 %

EPS (TTM)

₹  9.15

Sales Growth

-3.85%

ROE

17.04 %

ROCE

20.01%

Profit Growth

-5.27 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Advanced Enzyme Technologies Ltd.

evoxx DigeGrain DigePhos SEBrew SEBMash SEBake SEBStar SEBYeast Extractase Addclean

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-3.85%
3 Year8.81%
5 Year7.28%

Profit Growth

1 Year-5.27%
3 Year23.4%
5 Year12.06%

ROE%

1 Year17.04%
3 Year15.9%
5 Year15.48%

ROCE %

1 Year20.01%
3 Year19.72%
5 Year19.82%

Debt/Equity

0

Price to Cash Flow

58.37

Interest Cover Ratio

239.1976

CFO/PAT (5 Yr. Avg.)

0.73223219005447

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 43.08 0.00
Dec 2024 42.93 0.00
Sep 2024 42.95 0.00
Jun 2024 43.02 0.00
Mar 2024 43.49 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 23.395751551776% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 239.1976.
  • The Company has been maintaining an effective average operating margins of 26.92168% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 5.1945.

 Limitations

  • The company has shown a poor revenue growth of 8.8072139151274% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 92.4 85.96 77.38 100.87 87.21
Total Expenditure 63.16 65.04 63.85 78.81 73.04
Operating Profit 29.24 20.92 13.53 22.06 14.17
Other Income 3.21 53.88 1.66 1.43 4.53
Interest 0.05 0.02 0.08 0.06 0.08
Depreciation 3.07 2.62 2.78 2.89 3.11
Exceptional Items -18.95 0 0 0 0
Profit Before Tax 10.39 72.16 12.32 20.54 15.51
Tax 7.25 5.1 3.2 5.36 4.46
Profit After Tax 3.14 67.06 9.13 15.18 11.05
Adjusted EPS (Rs) 0.28 6 0.82 1.36 0.99

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 283.47 272.8 311.53 365.47 351.41
Total Expenditure 182.62 199.97 236.45 260.18 280.46
Operating Profit 100.85 72.83 75.08 105.29 70.95
Other Income 6.82 9.08 9.81 58.94 61.49
Interest 0.24 0.27 0.33 0.39 0.51
Depreciation 9.01 9.56 10.28 10.9 11.41
Exceptional Items 0 0 0 -18.95 0
Profit Before Tax 98.43 72.07 74.28 133.99 120.53
Tax 27.42 17.56 18.75 25.87 18.11
Net Profit 71.01 54.51 55.53 108.12 102.42
Adjusted EPS (Rs.) 6.36 4.88 4.97 9.67 9.15

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 22.35 22.36 22.37 22.37 22.38
Total Reserves 413.1 457.99 502.97 558.11 606.97
Borrowings 0.18 0 0 0 0
Other N/C liabilities 12.94 12.96 13.57 12.45 14.59
Current liabilities 41.04 36.31 36.9 40.01 44.7
Total Liabilities 489.6 529.62 575.8 632.93 688.63
Assets
Net Block 132.22 132.03 142.86 142.13 156.5
Capital WIP 1.96 3.25 5.61 16.45 20.74
Intangible WIP 5.38 5.44 5.42 5.41 0.02
Investments 151.56 172.68 185.48 205.49 253.71
Loans & Advances 35.14 35.76 38.36 14.73 19.46
Other N/C Assets 3.12 3.79 8.54 0.39 6.01
Current Assets 160.23 176.69 189.54 248.34 232.2
Total Assets 489.6 529.62 575.8 632.93 688.63
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 98.43 72.07 74.28 133.99 120.53
Adjustment 3.56 1.68 5.07 -23.59 -43.7
Changes in Assets & Liabilities 9.07 -15.21 -12.6 -31.57 8.19
Tax Paid -26.83 -21.44 -16.46 -27.21 -21.55
Operating Cash Flow 84.23 37.1 50.3 51.63 63.48
Investing Cash Flow -69.91 -14.24 -42.35 -2.7 -1.74
Financing Cash Flow -15.49 -10.87 -11.99 -56.88 -57.63
Net Cash Flow -1.16 11.99 -4.05 -7.95 4.11

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 43.49 43.02 42.95 42.93 43.08
jayesh madhusudan soni - - 0.03 0.03 0.03
kishor laxminarayan rathi... 1.31 1.31 1.35 1.35 0.36
kishor laxminarayan rathi... - - - - 0.98
madhusudan kabra 0.64 0.64 0.55 0.55 0.55
megha jhawar - - 0.02 0.02 0.02
payal akshay kulkarni - - 0.02 0.02 0.01
prabhavati vasant rathi 0.82 0.82 0.82 0.82 0.82
rachana vasant rathi 2.36 2.36 2.36 2.36 2.36
rasika vasant rathi 2.38 2.38 2.38 2.38 2.38
reshma namita rathi 2.37 2.37 2.37 2.37 2.37
snehal shamsunder soni - - - - 0.01
vasant rathi 33.14 33.14 33.04 33.03 33.18
advanced vital enzymes pv... 0.44 - - - -
chandrakumar laxminarayan... 0.04 - - - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 56.51 56.98 57.05 57.07 56.92
clarus capital i 1.28 1.51 1.82 1.99 2.15
icici prudential pharma h... - - - - 3.08
investor education and pr... - - 0.11 - 0.11
marval guru fund - - 1.00 1.00 1.00
mukund madhusudan kabra 1.63 1.63 1.63 1.63 1.63
nalanda india equity fund... 8.91 8.46 8.46 8.46 8.46
orbimed asia iii mauritiu... 2.20 12.08 12.08 12.07 12.07
pradip bhailal shah 1.81 1.80 1.71 1.70 1.70
hdfc small cap fund 3.67 3.33 3.02 2.96 -
investor education and pr... 0.11 0.11 - 0.12 -
icici prudential esg fund... 1.77 1.52 - - -
llp 0.24 0.24 - - -
orbimed asia iii mauritiu... 9.88 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities
Research HDFC Securities
Research HDFC Securities
Research Emkay

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY22
Concall Q4FY21
Concall Q3FY25
Concall Q3FY24
Concall Q3FY22
Concall Q2FY24
Concall Q2FY22
Concall Q2FY21
Concall Q1FY24
Concall Q1FY22
Concall Q1FY19
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY21
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY21
Presentation Q2FY20
Presentation Q1FY22
Presentation Q1FY21

Company News

Advanced Enzyme - Quaterly Results 13 May, 12:29 PM Advanced Enzyme - Quaterly Results 13 May, 12:29 PM Advanced Enzyme - Quaterly Results 13 May, 12:29 PM Advanced Enzyme Technologies informs about analyst meet 12 Mar, 12:37 PM Advanced Enzyme - Quaterly Results 8 Feb, 12:50 PM Advanced Enzyme - Quaterly Results 8 Feb, 12:50 PM Advanced Enzyme - Quaterly Results 8 Feb, 12:50 PM Advanced Enzyme Technologies completes further investment in AEE 19 Dec, 4:59 PM Advanced Enzyme Technologies informs about analyst meet 16 Dec, 5:13 PM Advanced Enzyme Technologies’ arm gets nod for formation of new corporation in California 5 Dec, 3:51 PM Advanced Enzyme Technologies informs about acquisition 5 Dec, 2:47 PM Advanced Enzyme Technologies informs about press release 11 Nov, 5:01 PM Advanced Enzyme - Quaterly Results 9 Nov, 10:56 AM Advanced Enzyme - Quaterly Results 9 Nov, 10:56 AM Advanced Enzyme - Quaterly Results 9 Nov, 10:56 AM Advanced Enzyme - Quaterly Results 10 Aug, 11:16 AM Advanced Enzyme - Quaterly Results 10 Aug, 11:16 AM Advanced Enzyme - Quaterly Results 10 Aug, 11:16 AM Advanced Enzyme Technologies informs about disclosure 12 Jun, 10:59 AM Advanced Enzyme Technologies informs about newspaper publication 13 May, 12:59 PM Advanced Enzyme - Quaterly Results 11 May, 1:40 PM Advanced Enzyme - Quaterly Results 11 May, 1:40 PM Advanced Enzyme - Quaterly Results 11 May, 1:40 PM Advanced Enzyme Technologies informs about earnings call transcript 21 Feb, 2:56 PM Advanced Enzyme Technologies informs about disclosure 20 Feb, 10:41 AM Advanced Enzyme Technologies gets nod to acquire additional stake of 5.89% in JC Biotech 10 Feb, 4:16 PM Advanced Enzyme - Quaterly Results 10 Feb, 12:41 PM Advanced Enzyme - Quaterly Results 10 Feb, 12:41 PM Advanced Enzyme - Quaterly Results 10 Feb, 12:41 PM Advanced Enzyme Technologies submits analyst meet intimation 3 Jan, 2:47 PM Advanced Enzyme Technologies informs about disclosures 18 Dec, 5:08 PM Advanced Enzyme Technologies informs about disclosure 15 Dec, 2:51 PM Advanced Enzyme Technologies informs about disclosures 7 Dec, 5:03 PM Advanced Enzyme Technologies informs about disclosures 30 Nov, 4:31 PM Advanced Enzyme Technologies informs about disclosures 20 Nov, 4:48 PM Advanced Enzyme Technologies informs about transcript of conference call 17 Nov, 5:03 PM Advanced Enzyme Technologies informs about disclosure 17 Nov, 2:35 PM Advanced Enzyme Technologies informs about disclosures 15 Nov, 5:10 PM Advanced Enzyme - Quaterly Results 7 Nov, 12:25 PM Advanced Enzyme - Quaterly Results 7 Nov, 12:25 PM Advanced Enzyme - Quaterly Results 7 Nov, 12:25 PM Advanced Enzyme Technologies informs about analyst meet 1 Nov, 4:46 PM Advanced Enzyme Technologies informs about disclosure 27 Sep, 2:32 PM Advanced Enzyme Technologies informs about disclosures 13 Sep, 4:51 PM Advanced Enzyme Technologies informs about disclosure 7 Sep, 10:31 AM Advanced Enzyme Technologies informs about transcript of conference call 23 Aug, 10:41 AM Advanced Enzyme Technologies informs about disclosure 18 Aug, 1:09 PM Advanced Enzyme Technologies informs about investor meeting 17 Aug, 5:04 PM Advanced Enzyme - Quaterly Results 12 Aug, 11:12 AM Advanced Enzyme - Quaterly Results 12 Aug, 11:12 AM

Advanced Enzyme Stock Price Analysis and Quick Research Report. Is Advanced Enzyme an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Advanced Enzyme and its performance over the period of time. Advanced Enzyme stock price today is Rs 333.9.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Advanced Enzyme cash from the operating activity was Rs 63.479 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Advanced Enzyme has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Advanced Enzyme , the EPS growth was -5.3202 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Advanced Enzyme has OPM of 20.1897493248646 % which is a good sign for profitability.
     
  • ROE: Advanced Enzyme have a average ROE of 17.044 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Advanced Enzyme is Rs 333.9. One can use valuation calculators of ticker to know if Advanced Enzyme share price is undervalued or overvalued.
Last Updated on:
Brief about Advanced Enzyme

Advanced Enzyme Technologies Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Advanced Enzyme Technologies Ltd. is a global player in the enzyme industry, specializing in research, development, manufacturing, and marketing of enzymes and probiotics. The company caters to a wide range of industries including human health, animal nutrition, baking, brewing, food processing, textile, and more. With a strong focus on innovation and sustainability, Advanced Enzyme Technologies has established itself as a trusted name in the enzyme market.

Advanced Enzyme Technologies Ltd. - Share Price

Stay up-to-date with the latest share price of Advanced Enzyme Technologies Ltd. Our website provides a real-time stock price tracking feature that allows investors to monitor the movement of the company's shares and make informed decisions. Whether you are a seasoned investor or just starting out, our user-friendly platform provides all the tools you need to stay informed about Advanced Enzyme Technologies' share price.

Advanced Enzyme Technologies Ltd. - Balance Sheet

Access the balance sheet of Advanced Enzyme Technologies Ltd. on our website. Our pre-built screening tools enable investors to analyze the financial health of the company. You can evaluate key performance indicators, such as revenue growth, profitability, and debt levels, to get a comprehensive overview of Advanced Enzyme Technologies' financial position.

Advanced Enzyme Technologies Ltd. - Annual Report

The annual report of Advanced Enzyme Technologies Ltd. is available for download on our website. This detailed report provides a comprehensive analysis of the company's performance over the past year. Investors can gain valuable insights into the company's strategies, financial results, market outlook, and future prospects. Our platform offers a user-friendly interface to access and navigate through the annual report easily.

Advanced Enzyme Technologies Ltd. - Dividend

Stay informed about the dividend history and payout policy of Advanced Enzyme Technologies Ltd. Our website provides a dedicated section where you can find the company's dividend record. Whether you are interested in regular income from dividend payouts or assessing the company's dividend stability, our platform provides the necessary information to make informed investment decisions.

Advanced Enzyme Technologies Ltd. - Quarterly Result

Analyze the quarterly financial performance of Advanced Enzyme Technologies Ltd. on our website. Our premium features allow investors to calculate fair value using analysis tools like the discounted cash flow (DCF) analysis, book value per share (BVPS) analysis, earnings multiple approach, and DuPont analysis. Stay up-to-date with the company's earnings, revenue growth, and key financial ratios to make informed investment decisions.

Advanced Enzyme Technologies Ltd. - Stock Price

Monitor the historical stock price movement of Advanced Enzyme Technologies Ltd. on our website. Our platform offers interactive price charts that provide a visual representation of the company's stock performance over time. Whether you are interested in assessing short-term trends or long-term patterns, our stock price charts will help you analyze the historical performance of Advanced Enzyme Technologies' stock.

Advanced Enzyme Technologies Ltd. - Price Chart

Our website features a comprehensive price chart of Advanced Enzyme Technologies Ltd. stock. This interactive chart allows investors to analyze the historical price movements, identify trends, and spot potential investment opportunities. Whether you are a technical analyst or a long-term investor, our price chart provides valuable insights into the stock's performance.

Advanced Enzyme Technologies Ltd. - News

Stay updated with the latest news and developments about Advanced Enzyme Technologies Ltd. Our website provides a reliable source of news articles related to the company. Investors can stay informed about industry trends, regulatory changes, product launches, partnerships, and other significant events that can impact Advanced Enzyme Technologies' business. Our news section keeps investors abreast of the latest updates, ensuring they have access to the information necessary to make informed investment decisions.

Advanced Enzyme Technologies Ltd. - Concall Transcripts

Access the conference call transcripts of Advanced Enzyme Technologies Ltd. on our website. Our platform provides downloadable transcripts of the company's earnings calls and other important conference calls. These transcripts offer investors an opportunity to gain insights into the company's management discussions, key announcements, and future plans. Reviewing the concall transcripts can provide valuable information for long-term stock investors.

Advanced Enzyme Technologies Ltd. - Investor Presentations

Download and review the investor presentations of Advanced Enzyme Technologies Ltd. on our website. These presentations offer a detailed overview of the company's business, financial performance, growth strategies, and key milestones. Investors can examine the company's market position, competitive advantage, and growth potential through these presentations. Stay informed and gain a deeper understanding of Advanced Enzyme Technologies' investment prospects through these investor presentations.

Advanced Enzyme Technologies Ltd. - Promoters

Learn about the promoters of Advanced Enzyme Technologies Ltd. Our website provides information about the key individuals driving the company's growth and success. Promoters play a crucial role in shaping the company's future and their expertise and vision contribute significantly to its performance. Understanding the background and qualifications of the promoters can assist investors in evaluating the leadership of Advanced Enzyme Technologies.

Advanced Enzyme Technologies Ltd. - Shareholders

Discover the major shareholders of Advanced Enzyme Technologies Ltd. Our website provides insights into the company's ownership structure, including institutional investors and individual shareholders. Understanding the composition of the shareholder base can offer valuable information about the market sentiment and confidence in the company's prospects. Monitor changes in the shareholder structure to stay informed about investor sentiment towards Advanced Enzyme Technologies.

Remember, you can access the annual reports, concall transcripts, investor presentations, credit ratings, and research reports of Advanced Enzyme Technologies Ltd. on our website. Our platform also offers premium features such as fair value calculations using tools like DCF analysis, BVPS analysis, earnings multiple approach, and DuPont analysis. Invest with confidence using the comprehensive analysis and information available on our website. 

Advanced Enzyme Technologies Balance Sheet Growth

Advanced Enzyme Technologies Sturdy Reserves

Advanced Enzyme Technologies has consistently strengthened its financial foundation, with total reserves climbing from Rs. 348.15 Cr in March 2020 to Rs. 558.11 Cr by March 2024. This resilient growth signifies the company's retention of earnings and potential for future investment.

Advanced Enzyme Technologies' Debt-Free Status

Remarkably, Advanced Enzyme Technologies has achieved a debt-free status by March 2022, with zero borrowings from that period onwards. This elimination of debt reflects prudent financial management and positions the company well for sustainable growth.

Advanced Enzyme Technologies' Asset Enhancement

The company's asset base has seen a measured increase, with net block assets almost stable and a significant rise in investments, going from Rs. 119.85 in March 2020 to Rs. 205.49 Cr by March 2024, showcasing a focus on asset accumulation for potential returns.

Advanced Enzyme Technologies' Current Financial Health

Current assets have grown from Rs. 125.36 Cr in March 2020 to a robust Rs. 248.34 Cr by March 2024, pointing towards a solid grasp on liquidity and operational efficiency for Advanced Enzyme Technologies.

This analysis pertains to the Standalone Balance sheet of Advanced Enzyme Technologies. As investors consider stock prospects within the biotechnology sector, Advanced Enzyme Technologies' consistent financial performance remains a noteworthy factor amidst other NSE/BSE listed entities.

Read More
X